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To investigate the possible involvement of antigen-pro-
cessing genes in the pathogenesis of psoriasis, we ana-
lyzed the polymorphisms of the TAP1, TAP2, LMP2,
LMP7, DMA, and DMB genes in 98 Korean psoriasis
patients and compared them with 184 healthy controls.
The frequencies of TAP2nB/B [relative risk (RR)¼ 3.6,
po0.0002] and TAP2nB (RR¼1.7, po0.05) were signi¢-
cantly increased, but TAP1nB (RR¼ 0.3, po0.002)
and TAP2nA (RR¼ 0.6, po0.03) were signi¢cantly
decreased, in the patients compared to the controls.
We performed further analysis on the TAP1 and TAP2
single nucleotide polymorphisms and found signi¢cant
di¡erences between the patients and controls in TAP1
single nucleotide polymorphism at position 637 and in
TAP2 at 665. In HLA-DM, DMAn0102 (RR¼ 2.5,
po0.0003) was signi¢cantly increased, but DMAn0101/
0101 (RR¼ 0.4, po0.0004) and DMBn0103/0103 (RR¼
0.3, po0.005) were signi¢cantly decreased in the patients
compared to the controls. The TAP and HLA-DM
alleles were also analyzed according to the age of onset
of psoriasis in the patients (types I and II). It was found
that the HLA-DM alleles showed a greater association in
type I than type II patients. An analysis of the linkage
disequilibrium and strati¢cation also indicated that the
alleles of TAP and HLA-DM might be independently
associated with HLA-Cwn0602 in psoriasis patients.
The strati¢cation analysis between DMAn0101/0101 and
DMBn0103/0103 showed that a certain factor, controlled
by a gene located between DMA and DMB, might pro-
vide strong protection against psoriasis, independently
of Cwn0602, in our Korean population. In conclusion,
our data suggest that the TAP and HLA-DM alleles
could lead to genetic susceptibility toward psoriasis
in Koreans. Key words: psoriasis/HLA-DM/LMP/TAP.
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P
soriasis lesions are characterized by epidermal hyper-
plasia and the presence of acute and chronic in£amma-
tory cells. Activated lymphocytes, other immune acces-
sory cells, and lymphokines have also been detected in
psoriasis plaques (Elder et al, 1994; Henseler, 1998). It has
been estimated that in most countries 1%^3% of the population
are a¡ected by psoriasis (Ikaheimo et al, 1996). Psoriasis is believed
to be a multigene disease, the expression of which is partially
dependent on external factors (Traupe, 1995). HLA-Cw6 shows
the most pronounced increase without regard to race or ethnicity,
supporting the presence of genes within the major histocompat-
ibility complex (MHC) to be the most important genetic factors
for determining susceptibility to psoriasis (Tiilikainen et al, 1980).
Recently, genome-wide scans have provided evidence suggesting
a linkage between psoriasis and the HLA and several non-HLA
loci. Of these, the HLA-linked locus (PSORS1) has been sug-
gested as the major locus for the susceptibility to psoriasis (Trem-
bath et al, 1997; Veal et al, 2001). PSORS1 contains ¢ve known
genes, three predicted transcripts, and a number of expressed se-
quence tags (Oka et al, 1999). These genes have been analyzed, and
signi¢cant associations have been detected for the nonconserva-
tive coding polymorphisms within the corneodesmosin (CDSN)
and HCR. Several studies have reported a signi¢cant association
for a coding single nucleotide polymorphism (SNP) in the
CDSN gene (Allen et al, 1999; Jenisch et al, 1999; Tazi Ahnini et
al, 1999), but this association was not observed in certain ethnic
groups, including the Japanese and Finnish (Ishihara et al, 1996;
Enerback et al, 2000). Asumalahti et al have demonstrated the
HCR gene to be ubiquitously expressed but upregulated in psor-
iatic epidermis, with a signi¢cant association between psoriasis
and the HCR alleles (Asumalahti et al, 2000). Other studies have
suggested that this association of the HCR with psoriasis was
solely due to the linkage disequilibria (LD) with Cwn0602 and
had no pathologic relevance (O’Brien et al, 2001). Therefore, it is
still unclear if these genes, or regions, are directly involved in the
predisposition to psoriasis, or if they are closely linked to other
disease-related genes, forming part of a larger disease-associated
haplotype.
In addition to HLA genes, immune responses are dependent
on several genes encoding molecules that generate and translocate
antigenic peptides.The genes involved in the class I and II antigen
processing pathways possess TAP, LMP, and HLA-DM, and may
be considered as candidate genes for the susceptibility to psoriasis.
The TAP genes are located in the HLA class II region, between
the DQB1 and DPA1 loci, and exhibit genetic polymorphisms.
The TAP genes consist of the TAP1 and TAP2 genes, which en-
code a heterodimer molecule that forms a heterodimeric complex
Reprint requests to: Dr.Tai-Gyu Kim, Department of Microbiology and
Immunology, College of Medicine,The Catholic University of Korea, 505
Banpo-Dong, Seocho-Ku, Seoul 137-701, Korea; Email: kimtg@cmc.cuk.
ac.kr
Abbreviations: ARMS, ampli¢cation refractory modi¢cation system;
HF, haplotype frequency; LD, linkage disequilibrium; OR, odds ratio;
SNP, single nucleotide polymorphism; SSCP, single-strand conformation
polymorphism;TAP, transporter associated with antigen processing.
Manuscript received July 24, 2002; revised October 1, 2002; accepted for
publication December 10, 2002
0022-202X/03/$15.00  Copyrightr 2003 by The Society for Investigative Dermatology, Inc.
616
for delivering antigenic peptides to the endoplasmic reticulum
prior to the assembly of class I molecules (Deverson et al, 1990;
Spies et al, 1990;Trowsdale et al, 1990).Two polymorphic sites have
been found in the TAP1 gene, and four in the TAP2. With the
TAP1 and TAP2 there are four and eight possible allele combina-
tions of polymorphisms, respectively, at these sites (Powis et al,
1993). The LMP2 and LMP7 genes are located within the class II
region, and encode two subunits of the proteasome complex in-
volved in the degradation of cytosolic proteins and the generation
of antigenic peptides (Brown et al, 1991; Ortiz-Navarrete
et al, 1991). Although the LMP proteolytic enzymes may not be
essential for the processing of peptides bound by MHC class
I molecules (Arnold et al, 1992), they may amplify speci¢c endo-
peptidase activities of the proteasome, generating peptides suita-
ble for MHC class I molecules. The HLA-DM genes catalyze
peptide loading into the HLA class II molecules (Kelly et al,
1991a), are located in the HLA class II region, between the
DQB1 and DPB1 loci, and exhibit genetic polymorphisms
(Carrington et al, 1993b; Carrington and Harding, 1994). The
HLA-DM gene polymorphisms may in£uence peptide loading
on the HLA class II molecules. Thus, the TAP, LMP, and HLA-
DM may play a restrictive role in antigen processing and presen-
tation, and so are attractive candidates as additive susceptibility
factors toward psoriasis. In this study, we examined the poly-
morphisms of the TAP1, TAP2, LMP2, LMP7, HLA-DMA, and
HLA-DMB genes, and their association with psoriasis, in a popu-
lation of Korean patients.
MATERIALS AND METHODS
Subjects The study population comprised of 96 Korean psoriasis patients,
44 females and 52 males, with an age range from 12 to 83 y. The patients
were divided into two groups based on their age at the onset of psoriasis;
type I (n¼ 73), below 30 y and II (n¼ 23), above 30 y (Kim et al, 2000). The
average age at onset of psoriasis was 23.4 y. Their results were compared with
184 controls without psoriasis. All the subjects gave their formal agreement for
a genomic study and Ethical approval was obtained from The Catholic
university of Korea’s Human Research Ethics Committee.
TAP gene polymorphisms The TAP alleles were determined by
the polymerase chain reaction (PCR) single-strand conformation
polymorphism (SSCP) and PCR ampli¢cation refractory modi¢cation
system (ARMS) methods as previously reported (Powis et al, 1993).
PCR-SSCP analysis of TAP1 at codons 333 and 637, andTAP2 at codons 379 and
665 The PCRwere carried out with primers in a volume of 10 ml with
10 bu¡er (500 mM KCl, 100 mMTris^HCl pH 8.3 and 15 mMMgCl2); 1
pM of each oligonucleotide primer; dNTP (200 mM each of dATP, dGTP,
and dTTP, and 100 mM of dCTP); 5 mCi [a-32P]dCTP; 100 ng of genomic
DNA; and 0.5 U Taq DNA polymerase (5 U per ml; Boehringer Man-
nheim, Mannheim, Germany). The PCRwere carried out in a Perkin El-
mer 9600 thermocycler (PE Biosystems, Foster City, CA) under the
following conditions: 5 min at 951C; 35 cycles of 30 s at 951C (denatura-
tion), 30 s at 621C (annealing), and 40 s at 721C (elongation); and ¢nally 10
min at 721C. The PCR products were mixed with a solution of 10 mM
NaOH, 95% formamide, 0.05% bromophenol, and 0.05% xylene cyanol
and denatured at 951C for 2^3 min. The products were separated on a 6%
nondenaturing acrylamide gel for 4 h at 41C and 50 W. For the autoradio-
graphy, the gels were ¢xed, dried, and exposed for 2^18 h using an X-ray
¢lm at701C and an intensifying screen.
PCR-ARMS analysis forTAP2 gene polymorphism at codon 565 DNA samples
(100 mg per ml) were ampli¢ed in reaction mixtures containing Taq DNA
polymerase (Boehringer Mannheim), 10 bu¡er, primers, 200 mM dNTPs,
and distilled water. The PCRwas carried out in a Perkin Elmer 9600 ther-
mocycler (PE Biosystems) under the following conditions: 5 min at 951C;
35 cycles of 1 min at 951C (denaturation), 1 min at 621C (annealing), and 1
min at 721C (elongation); and ¢nally 10 min at 721C. The ampli¢ed PCR
products were separated on a 1.5% agarose gel and stained with ethidium
bromide.
Allelic assignments forTAP1 andTAP2 The amino acids at the polymorphic
positions 333 and 637 in the TAP1 gene, and 379, 565, and 665 in the TAP2
gene, were analyzed. Each position is an SNP: TAP1333 (A-G, Ile-Val)
and TAP1637 (A-G, Asp-Gly); and TAP2379 (G-A, Val-Ile), TAP2565
(G-A, Ala-Thr), and TAP2665 (A-G, Thr-Ala). Each allele of the
TAP1 and TAP2 genes was de¢ned by the combination of polymorphisms
at di¡erent positions, as follows: TAP1nA (Ile-333 and Asp-637), TAP1nB
(Val-333 and Gly-637), and TAP1nC (Val-333 and Asp-637); and TAP2nA
(Val-379, Ala-565, and Thr-665),TAP2nB (Val-379, Ala-565, and Ala-665),
TAP2nC (Ile-379, Ala-565, and Thr-665), TAP2nD (Ile-379, Thr-565, and
Thr-665), TAP2nE (Val-379, Thr-565, and Thr-665), and TAP2nG (Ile-379,
Ala-565, and Ala-665).
LMP gene polymorphisms The genotyping of the LMP2 and LMP7
were carried out by PCR restriction fragment length polymorphism as
previously described (Kelly et al, 1991b). The polymorphic positions at
nucleotides 3911, 3912, and 4069 in the LMP7 gene, and at the amino
acid position 60 in the LMP2 gene, were analyzed [LMP73911 (T-G),
LMP73912 (C-T), and LMP74069 (C-T); and LMP260 (G-A, Arg-His)].
The LMP7 alleles were de¢ned by the combination of poly-
morphisms at di¡erent positions, as follows: LMP7nA (T-3911, C-3912,
and C-4069), LMP7Bn (G-3911, C-3912, and C-4069), LMP7nC (C-3911,
C-3912, and T-4069), and LMP7nD (G-3911, T-3912, and T-4069). LMP2
alleles were assigned as LMP2nR (Arg) and LMP2nH (His). The PCR
were carried out with primers in a volume of 20 ml with 10 bu¡er; 1
pM of each oligonucleotide primer; 200 mM dNTPs; 100 ng of genomic
DNA; and 0.5 U Taq DNA polymerase (Boehringer Mannheim). The
PCR were carried out in a Perkin Elmer 9600 thermocycler (PE
Biosystems) under the following conditions: (i) LMP2, 5 min at 951C and
35 cycles of 15 s at 951C (denaturation), 40 s at 671C (annealing), 30 s at
721C (elongation), and ¢nally 10 min at 721C; and (ii) LMP7, 5 min at
951C and 35 cycles of 7 s at 951C (denaturation), 30 s at 621C (annealing),
30 s at 721C (elongation), and ¢nally 10 min at 721C. The ampli¢ed PCR
products were subjected to digestion with a restriction endonuclease, Hha I
(USB, Cleveland, OH), at 371C for 1 h. After digestion, the LMP2
fragments were fractionated on an 8% acrylamide gel at 300 V for 2.5 h,
and the LMP7 fragments on a 2% agarose gel at 200 V for 30 min, and
were visualized by staining with ethidium bromide.
HLA-DM gene polymorphisms The genotyping of the HLA-DMA
and HLA-DMB was carried out by PCR-SSCP, as previously described
(Carrington et al, 1993b, Carrington and Harding, 1994). Based on
sequences from the third exon, four alleles of the DMA (DMAn0101,
n0102, n0103, and n0104) and ¢ve of the DMB (DMBn0101, n0102, n0103,
n0104, and n0105) were analyzed. These nucleotide positions involved
codons 140, 155, and 184 in the DMA and codons 144 and 179 in the
DMB, which all result in nonsynonymous amino acid changes: DMA140
(G-A,Val-Ile), DMA155 (G-C, Gly-Ala), DMA184^1 (C-T,Val-Ile),
and DMA184^2 (G-A, Arg-His); DMB144 (C-A, Ala-Glu; C-T,
Ala-Val) and DMB179 (T-C, Ile-Thr). Each DMA and DMB allele
was assigned by the combination of polymorphisms at di¡erent positions
as follows: DMAn0101 (Val-140, Gly-155, and Arg-184), DMAn0102 (Ile-
140, Gly-155, and Arg-184), DMAn0103 (Val-140, Ala-155, and His-184),
and DMAn0104 (Ile-140, Gly-155, and Cys-184); DMBn0101 (Ala-144 and
Ile-179), DMBn0102 (Glu-144 and Ile-179), DMBn0103 (Ala-144 and Thr-
179), DMBn0104 (Val-144 and Thr-179), and DMBn0105 (Val-144 and Ile-
179). The PCRwere carried out with primers in 10 ml with 10 bu¡er; 1
pM of each oligonucleotide primer; dNTP (200 mM each of dATP, dGTP,
and dTTP, and 100 mM dCTP); 5 mCi [a-32P]dCTP; 100 ng of genomic
DNA; and 0.5 U Taq DNA polymerase (Boehringer Mannheim). The
PCR were carried out in a Perkin Elmer 9600 thermocycler (PE
Biosystems) under the following conditions: 5 min at 951C; 30 cycles of
30 s at 951C (denaturation), 60 s at 651C (annealing), and 90 s at 721C
(elongation); and ¢nally 10 min at 721C. The PCR products were mixed
with a solution containing 10 mM NaOH, 95% formamide, 0.05%
bromophenol, and 0.05% xylene cyanol, and denatured at 951C for 2^3
min. The products were separated on a 6% nondenaturing acrylamide gel
for 4 h, at 41C and 50 W. For the autoradiography, the gels were ¢xed,
dried, and exposed for 2^18 h using an X-ray ¢lm at ^701C and an
intensifying screen.
HLA-C genotyping The HLA-C typing was performed using PCR-
ARMS by the previously described method (Bunce and Welsh, 1994).
Each tube contained a primer mix consisting of the allele- or group-
speci¢c primer pairs, with a positive control primer matched to the
nonallelic sequences. The HLA-C typing included 23 sets of primer
mixtures. The PCR were performed in 7 ml, modi¢ed from the Twelfth
International Histocompatibility Workshop reference manual for class I
ARMS-PCR. The sizes of the PCR products were de¢ned on 1.5%
agarose gel, prestained with ethidium bromide.
Statistics The odds ratios (OR) were calculated using Woolf ’s formula
(Haldane, 1955) and by convention, and were expressed as the relative risk
(RR). Haldane’s modi¢cation of the formula was used when one element
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of the equation was zero. Any statistically signi¢cant di¡erence was tested
by w2 analysis with 1 degree of freedom or by a two-tailed Fisher’s exact
test when the criteria for the w2 analysis were not ful¢lled. A p-value of
less than 0.05 was considered statistically signi¢cant. Delta values for the
LD and haplotype frequency (HF) were calculated by the formula of
Mattiuz et al (1970). An exact test (Guo and Thompson, 1992) was
employed to evaluate deviations from the expected Hardy^Weinberg
genotypic proportions, using the Arlequin computer program package
(Schneider et al, 1996).
RESULTS
Frequencies of TAP1,TAP2, LMP2, LMP7, DMA, and DMB
alleles We tested the Hardy^Weinberg equilibria of all genes
studied in the control group with the exception of the TAP2, as
not all heterozygotes can be discriminated using our typing
system. The genotype distributions were consistent with the
assumption of the Hardy^Weinberg equilibrium, with the
possible exception of the LMP7, due to an excess of
homozygotes (the observed and expected frequencies were
50.5% and 60.3%, respectively).
The frequencies of the TAP1 and TAP2 alleles for the patients
and controls are shown inTable I. The frequencies of TAP2nB/B
(RR¼ 3.6, po0.0002) and TAP2nB (RR¼1.7, po0.05) were
signi¢cantly increased, but those of TAP1nA/B (RR¼ 0.4,
po0.02),TAP1nB (RR¼ 0.3, po0.002), and TAP2nA (RR¼ 0.6,
po0.03), were signi¢cantly decreased, in the patients compared to
the controls. To exclude the unclear assignment of some alleles
due to heterozygosity at more than one residue, we also
analyzed individual TAP SNPs. There were signi¢cant
di¡erences in the frequencies of the TAP1 SNP at the 637
position and the TAP2 at the 665 position between the patients
and controls (Table I). At the TAP1-637 residue, the geno-
type frequency of Asp-637/Asp-637 homozygote (RR¼ 2.6,
po0.003) and the gene frequency of Asp-637 (RR¼ 2.5,
po0.002) were signi¢cantly increased in the patients compared
to the controls. The phenotype and gene frequencies of Gly-637
position were signi¢cantly decreased in the patients compared
to the controls. At the TAP2-665 position, the frequencies of
Ala-665/Ala-665 (RR¼ 3.4, po0.003), Ala-665 phenotype
(RR¼ 2.0, po0.02), and Ala-665 gene (RR¼1.9, po0.0004)
were signi¢cantly increased, but Thr-665/Thr-665 (RR¼ 0.5,
po0.02), Thr-665 phenotype (RR¼ 0.3, po0.0002), and Thr-
665 gene (RR¼ 0.5, po0.0004) were signi¢cantly decreased in
the patients compared to the controls. There were no signi¢cant
di¡erences in the TAP1-333, TAP2-379, and TAP2-565 SNPs
between the patients and controls (data not shown).
Table II shows the frequencies of the HLA-DM alleles in the
patients and controls. The frequencies of DMAn0101/0102
(RR¼ 2.0, po0.006) and DMAn0102 (RR¼ 2.5, po0.0003)
were signi¢cantly increased, but DMAn0101/0101 (RR¼ 0.4,
po0.0004) and DMBn0103/0103 (RR¼ 0.3, po0.005) were
signi¢cantly decreased, in the patients compared to the controls.
The frequencies of the LMP2 and LMP7 in the patients and
controls were studied, but no signi¢cant di¡erences were found
(data not shown).
Distribution of TAP, LMP, and HLA-DM alleles according
to age of onset We previously mentioned that types I and II
psoriasis were divided according to the age at onset of psoriasis,
i.e., below or above 30 y, respectively, in our Korean population
(Kim et al, 2000).We analyzed the frequencies of TAP and HLA-
DM alleles for type I and II psoriasis patients (Table III). The
frequencies of TAP2nB/B and DMAn0102 were signi¢cantly
increased in type I patients compared to the controls, but there
were no signi¢cant di¡erences of these two alleles between
types I and II patients, although the frequency of DMAn0102
was relatively increased in type I compared to type II patients.
Table I. TAP genotype and allele frequencies in Korean psoriasis patients and normal controls
TAP1 Psoriasis, n¼ 96 Controls, n¼184 RR p-value TAP2 Psoriasis, n¼ 96 Controls, n¼184 RR p-value
A/A 66 112 A/A 9 35
A/B 14 49 0.4 0.02 A/B 32 66
A/C 13 12 A/C 4 8
B/B 0 4 A/E 3 9
B/C 1 6 B/B 26 17 3.6 0.0002
C/C 2 1 B/E 4 12
A 93 173 B/G 1 3
B 15 59 0.3 0.002 C/C 0 1
C 16 19 C/D 0 2
D/E 0 1
E/E 0 1
X/X 17 29
 A 48 118 0.6 0.03
B 63 98 1.7 0.05
C 4 11
D 0 3
E 7 23
G 1 31.6
X 17 29
637 665
Asp/Asp 81 124 2.6 0.003 Ala/Ala 28 20 3.4 0.003
Asp/Gly 15 56 0.4 0.007 Ala/Thr 49 103
Gly/Gly 0 4 Thr/Thr 19 61 0.5 0.02
Asp 96 180 Ala 77 123 2.0 0.02
Gly 15 60 0.4 0.003 Thr 68 164 0.3 0.0002
n¼192 n¼ 368 n¼192 n¼ 368
Asp 177 304 2.5 0.002 Ala 105 143 1.9 0.0004
Gly 15 64 0.4 0.002 Thr 87 225 0.5 0.0004
X, A/G, B/C, B/D, E/G, A/D, or C/E
(TAP2nA/TAP2nG and TAP2nB/TAP2nC,TAP2nB/TAP2nD and TAP2nE/TAP2nG,TAP2nA/TAP2nD and TAP2nC/TAP2nE heterozygotes cannot be distinguished by
the typing system that we designed.)
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There were also signi¢cant di¡erences of TAP1nB, DMAn0101/
0101, and DMBn0103/0103 between the type I patients and
controls. The HLA-DM alleles showed a greater decrease in
type I patients than type II, although this was not statistically
signi¢cant.
LD and HF between the TAP1, TAP2, DMA, and DMB
alleles Table IV shows the two-loci haplotypes of the TAP1,
TAP2, DMA, and DMB to have signi¢cant (po0.05) positive
LD and frequencies of more than 5% in the psoriasis patients.
We found a number of signi¢cant (both positive and negative)
LD among these alleles, which were present to di¡erent extents
in the patients compared with the controls, but these linked
alleles only showed a low LD when compared to the HF. These
results show the possibility that the region between the TAP and
HLA-DM may have a comparatively high recombination rate in
our population, as shown by other populations (van Endert et al,
1992; Carrington et al, 1993a).
Association of the TAP1, TAP2, DMA, and DMB with
CWn0602 We previously reported that HLA-Cwn0602 was
strongly associated with psoriasis in Koreans (Kim et al, 2000). In
this study, we also found that the frequency of Cwn0602 was
signi¢cantly increased in psoriasis patients compared to controls
(psoriasis patients versus normal controls 75.0% vs 6.5%,
RR¼ 43.0, po210^32). To determine if the observed
associations of the TAP1, TAP2, DMA, and DMB with psoriasis
were disease related or the consequence of an LD with Cwn0602,
we analyzed the LD and performed strati¢cation analysis
between the associated alleles and Cwn0602 in the patients and
controls. No signi¢cantly positive and negative disequilibria
were observed between the alleles and Cwn0602 in either the
patients or controls (Table V). The results of the strati¢cation
analysis are shown in Table VI (Svejgaard and Ryder, 1994).
Cwn0602 and the associated alleles of TAP1, TAP2, DMA, and
DMB were signi¢cantly associated with psoriasis in the test of
individual association [1]. Strati¢cation of Cwn0602 showed that
TAP2nB/B was signi¢cantly increased in the Cwn0602-negative
group, and TAP1nB and DMBn0103/0103 were signi¢cantly
decreased in the Cwn0602-positive group [2]. Cwn0602 was
signi¢cantly increased in the patients compared to the controls,
irrespective of the positivity or negativity for the associated
alleles of TAP1, TAP2, DMA, and DMB [3]. There were
signi¢cant di¡erences in associations between the associated
alleles and Cwn0602 for patients with psoriasis in an
investigation of whether the associations between Cwn0602 and
the associated alleles di¡er [4]. TAP2nB/B and DMAn0102 alleles
considerably increased the OR value of Cwn0602, but TAP1nB,
DMAn0101/0101, and DMBn0103/0103 alleles decreased that
of Cwn0602 in the test of a combined association [5]. Taken
together with the LD data and the strati¢ed analysis, these
results showed that TAP1, TAP2, DMA, and DMB alleles might
be independently associated with Cwn0602 in psoriasis patients,
although Cwn0602 was more strongly associated with psoriasis
than the other alleles.
Combined analysis of DMAn0101/0101 and DMBn0103/
0103 We investigated the relation of DMAn0101/0101 and
DMBn0103/0103 alleles in psoriasis because the two alleles
showed a signi¢cant association and LD in the patients (Table
VII). DMAn0101/0101 and DMBn0103/0103 were negatively
associated with psoriasis in a test of individual association [1].
Table II. DM genotype and allele frequencies in Korean psoriasis patients and normal controls
DMA Psoriasis, n¼ 96 Controls, n¼184 RR p-value DMB Psoriasis, n¼ 96 Controls, n¼184 RR p-value
0101/0101 44 124 0.4 0.0004 0101/0101 26 33
0101/0102 42 51 2.0 0.006 0101/0102 21 37
0101/0103 0 1 0101/0103 29 55
0102/0102 10 8 0102/0102 0 7
0102/0103 14 19
0103/0103 6 33 0.3 0.005
0101 86 176 0101 76 125
0102 52 59 2.5 0.0003 0102 35 63
0103 0 1 0103 49 107
Table III. Distribution of TAP, LMP, and HLA-DM alleles in type I and type II psoriasis patients compared to normal controls
Type Type I, n¼ 73 RR p-value Type II, n¼ 23 RR p-value Controls, n¼184
TAP1nB 12 0.5 0.02 3 59
TAP2nB/B 20 3.7 0.0002 6 17
TAP2nB 49 14 98
DMAn0101/0101 30 0.3 0.0002 14 124
DMAn0102 43 3.0 0.0002 9 59
DMBn0103/0103 4 0.3 0.02 2 33
Table IV. Analysis of two locus haplotypes among TAP1,TAP2, DMA, and DMB alleles showing signi¢cant association with
psoriasis in patient group
Haplotype þ þ þ ^þ ^ ^ LD (%) HF (%) p-value
TAP1nA^TAP2nB 63 12 0 3 11.0 38.0 0.02
DMAn0102^TAP2nB 42 3 21 12 10.7 26.9 0.003
DMAn0101^DMBn0102 35 51 0 10 6.5 15.6 0.02
DMAn0101^DMBn0103 49 37 0 10 9.7 23.1 0.0009
DMAn0102^DMBn0101 50 2 26 18 12.4 27.1 0.00001
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DMAn0101/0101 only showed a signi¢cant decrease in
DMBn0103/0103-negative groups but DMBn0103/0103 was
insigni¢cantly decreased in both DMAn0101/0101-positive and
DMAn0101/0101-negative groups in strati¢cation of the two
alleles [2, 3]. There were no signi¢cant di¡erences between the
two associations in a test of di¡erence between the two alleles’
association [4]. A signi¢cant combined association between the
two genotypes was shown [5], and there was a signi¢cant
association between the two genotypes in both the patients
and controls [6]. These results proved that DMAn0101/0101 and
DMBn0103/0103 might interact with each other, indicating a
certain stronger negative factor. We performed further analysis
on the haplotype of DMAn0101/0101^DMBn0103/0103 and
Cwn0602, which all showed signi¢cant decreases in the psoriasis
patients [1]. The haplotype was signi¢cantly decreased in the
Cwn0602-positive group but not in the Cwn0602-negative
group [2]. When Cwn0602 was strati¢ed for the presence or
absence of the haplotype, it was signi¢cantly increased in both
the haplotype-positive and haplotype-negative groups [3]. There
was a signi¢cant di¡erence between the two factors’ associations
TableV. Analysis of linkage disequilibrium between the associated alleles and HLA-Cwn0602 in psoriasis patients
and normal controls
Locus 1 Locus 2 Group þ þ þ ^ ^þ ^ ^ LD (%) p-value
TAP1nB Cwn0602 Psoriasis patients 11 4 61 20 ^0.3 ns
Normal controls 6 53 6 119 0.7 ns
TAP2nA Cwn0602 Psoriasis patients 35 13 37 11 ^1.5 ns
Normal controls 6 112 6 60 ^0.8 ns
TAP2nB/B Cwn0602 Psoriasis patients 19 7 53 17 ^0.6 ns
Normal controls 3 14 9 158 0.6 ns
TAP2nB Cwn0602 Psoriasis patients 50 13 22 11 4.5 ns
Normal controls 9 89 3 83 1.1 ns
DMAn0102 Cwn0602 Psoriasis patients 41 11 31 13 2.9 ns
Normal controls 4 55 8 117 0.1 ns
DMAn0101/0101 Cwn0602 Psoriasis patients 31 13 41 11 ^2.9 ns
Normal controls 8 116 4 56 0.04 ns
DMBn0103/0103 Cwn0602 Psoriasis patients 4 2 68 22 0.5 ns
Normal controls 4 29 8 143 0.6 ns
ns, not signi¢cant.
TableVII. Strati¢cation analysis between DMAn0101/0101 and DMBn0103/0103 and between the haplotype of DMAn0101/
0101DMBn0103/0103 and HLA-Cwn0602
Comparison [1] Independent
association
[2] Independent
A association
[3] Independent
B association
[4] Di¡erence
between A and B
association
[5] Combined
association
[6] Association
between A and B
Factor A Factor B A B þ þ vs ^þ þ ^vs ^ ^ þ þ vsþ ^ ^þ vs ^ ^ þ ^vs ^þ þ þ vs ^ ^ Patients Controls
DMAn0101/0101 DMBn0103/0103 0.4 0.3 0.5 0.2 9.5 22.5
DMA^DMB Cwn0602 0.3 43 0.1 14.5 55.3 0.008 6.5
[1] Test of individual factor association (A, A associated?; B, B associated?). [2] Independent factor A association (þ þ vs ^þ , A associated in B positives?;þ ^vs ^ ^, A
associated in B negatives?); [3] Independent factor B association (þ þ vsþ ^, B associated in A positives?; ^þ vs ^ ^, B associated in A negatives?). [4] Di¡erence between
A and B associations (^þ vs ^þ ). [5] Combined A^B association (þ þ vs ^ ^). [6] Association between A and B (patients, linkage between A and B in patients; controls,
linkage between A and B in patients).
DMA^DMB, haplotype of DMAn0101/0101^DMBn0103/0103. ORvalues indicate that the corresponding p-values are signi¢cant (po0.05).
TableVI. Strati¢cation analysis between the associated alleles and HLA-Cwn0602
Comparison [1] Individual
association
[2] Independent
A-association
[3] Independent
B-association
[4] Di¡erence
between A and B
association
[5] Combined
association
[6] Association
between A and B
Factor A Factor B A B þ þ vs ^þ þ ^vs ^ ^ þ þ vsþ ^ ^þ vs ^ ^ þ ^vs ^þ þ þ vs ^ ^ Patients Controls
TAP1nB Cwn0602 0.4 43.0 0.2 24.3 60.5 0.007 10.9
TAP2nB/B Cwn0602 3.6 43.0 4.6 12.7 54.7 0.09 58.9
DMAn0102 Cwn0602 2.5 43.0 51.3 34.9 0.05 92.3
DMAn0101/0101 Cwn0602 0.4 43.0 34.6 52.2 0.01 19.7
DMAn0103/0103 Cwn0602 0.3 43.0 0.1 14.5 55.3 0.008 6.5
[1] Test of individual factor association (A, A associated?; B, B associated?). [2] Independent factor A association (þ þ vs ^þ , A associated in B positives?;þ ^vs ^ ^, A
associated in B negatives?). [3] Independent factor B association (þ þ vsþ ^, B associated in A positives?; ^þ vs ^ ^, B associated in A negatives?). [4] Di¡erence between
A and B associations (^þ vs ^þ ). [5] Combined A^B association (þ þ vs ^ ^). [6] Association between A and B (patients, linkage between A and B in patients; controls,
linkage between A and B in patients).
ORvalues indicate that the corresponding p-values are signi¢cant (po0.05).
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[4]. The haplotype considerably decreased the OR value of
Cwn0602 with the combined association [5]. There was no
signi¢cant association between the haplotype and Cwn0602 in
either the psoriasis patients or controls [6]. These results therefore
indicate that some factor, controlled by a gene located between
DMA and DMB, might be associated with a strong protection
against psoriasis, independently of Cwn0602 association.
DISCUSSION
TheTAP genes are polymorphic, and due to their essential invol-
vement in class I antigen presentation might represent additional
susceptibility genes to disease. The functional consequences of
TAP polymorphisms are unknown. TAP molecules are required
not only for peptide transport, however, but also for the assembly
of class I heavy chain a2-microglobulin dimers and the previously
designed TAP-associated protein tapasin (Ortmann et al, 1997).
This interaction may be a target for consideration in the mechan-
ism where a TAP polymorphism is involved in the pathogenesis
of the disease. There have been several reports on the analysis of
TAP alleles in patients with psoriasis. Fakler et al (1994) analyzed
theTAP2 gene polymorphism in psoriasis, and showed no signif-
icant association between the alleles and psoriasis. Saeki et al
(1998) showed a decrease in TAP2nE allele in a Japanese popula-
tion of psoriasis patients. Hohler et al (1996) reported an increase
in TAP1nA allele in patients with early onset of psoriasis. We
found that the frequencies of TAP2nB and TAP2nB/B were sig-
ni¢cantly increased and TAP1nB and TAP2nA were decreased in
psoriasis patients compared with the controls (Table I).We per-
formed further analysis on the TAP1 and TAP2 SNPs and found
signi¢cant di¡erences in the frequencies of the TAP1 SNP at the
637 position and the TAP2 at the 665 position between the pa-
tients and the controls (Table I). In the TAP1 at residue 637, the
gene frequency of Asp-637 was signi¢cantly increased but Gly-
637 was decreased in the patients compared to the controls. In
the TAP2 at residue 665, Ala-665 was signi¢cantly increased but
Thr-665 was decreased in the patients compared to the controls.
There was also a signi¢cant LD between TAP1nA and TAP2nB
(Table IV) and between TAP1 Asp-637 and the TAP2 Ala-665
(LD¼ 3.8, po0.0001) in the patients compared to the controls.
Quadri and Singal (1998) indicated that TAP1nA and TAP1nC al-
leles might favor the e⁄cient transport of peptides with a basic
C-terminus, whereasTAP1nB allele might translocate peptides re-
gardless of the di¡erences in the C-terminal amino acid residue.
This is due to the acidic nature of Asp residue present at the ami-
no acid position 637 of TAP1nA andTAP1nC alleles, in contrast to
Gly in TAP1nB allele (Powis et al, 1993). The major contact site(s)
in the TAP1might be located in the extreme transmembrane and
cytoplasmic domains, close to the ATP binding site (Nijenhuis
et al, 1996), which is the region where the human TAP1 shows
polymorphism (Powis et al, 1992). The TAP1 allele (TAP1nA or
TAP1nC) containing the Asp residue at the 637 position, close to
the peptide binding site, might in£uence the peptide^TAP1 inter-
action and their eventual transport to the ER endoplasmic reticu-
lum (Quadri and Singal, 1998). Asahina et al reported that the Asp
at residue 9 and Ala at residue 73, on HLA-C molecules, were
strongly associated in Japanese psoriasis patients (Asahina et al,
1991; 1996). These residues might contribute to the formation of
a peptide-binding pocket in HLA-C molecules, especially
Cwn0602 (Kostyu et al, 1997). Although TAP2 alleles have been
shown not to a¡ect peptide transport, a commonly coexpressed
product of alternative splicing of the humanTAP2 transcript, dif-
fering in the C-terminal region of the protein, exhibits distinct
peptide selectivity (Yan et al, 1999). A single point mutation, gen-
erated by site-directed mutagenesis in the humanTAP2, has been
shown su⁄cient to a¡ect the peptide transport speci¢city
(Armandola et al, 1996). Neisig et al (1998) have shown some
HLA-C molecules to be more selective in their peptide binding
than the HLA-A and HLA-B molecules, resulting in prolonged
association with TAP, and a reduced formation of intracellular
HLA-C^peptide complexes. Binding of HLA class I and speci¢c
inhibitory natural killer (NK) receptors generates dominant inhi-
bitory signals that neutralize any positive signals in NK cells; thus
the self class I protects healthy cells from lysis by the NK. If this
does not happen, the NK cells trigger cytotoxicity. It has been
suggested that psoriasis may be triggered by the direct activation
of CD8 and/or NK Tcells bearing receptors for MHC class I mo-
lecules (Bos and De Rie, 1999). Therefore it could be thought that
the interaction of speci¢c TAP molecules and peptides might
cause altered activity of speci¢c HLA-C, such as low expression
on the cell surface, resulting in the activation of NK cell cyto-
toxicity to self cells in psoriasis patients, and the associated TAP
alleles in this study might play a role in the development of
psoriasis.
HLA-DM polymorphisms have been investigated in several
autoimmune diseases but the role of HLA-DM polymorphisms
in autoimmune diseases is not understood yet. Pinet et al (1997)
observed an increase in both DMBn0104 and DMAn0103 pheno-
types in rheumatoid arthritis. The homozygous DMBn0101/0101
was reported to be positively associated with rheumatoid arthritis
in Caucasians (Perdriger et al, 1999), butYen et al andTakeuchi et al
found no association of the HLA-DM with rheumatoid arthritis
in Taiwanese and Japanese populations (Takeuchi et al, 1997; Yen
et al, 1997). West and Reed (1999) reported that the frequencies
of DMAn0103 and DMBn0102 were increased in patients with ju-
venile dermatomyositis. Saeki et al (1999) reported that the fre-
quency of DMAn0102 was increased, and that of DMAn0101was
decreased, in Japanese psoriasis patients, but no signi¢cant asso-
ciation between DMB alleles and psoriasis was shown. To deter-
mine the association between HLA-DM polymorphisms and
psoriasis in the Korean population, we investigated the HLA-
DM polymorphisms, and found the frequency of DMAn0102 to
be signi¢cantly increased and DMAn0101/0101 and DMBn0103/
0103 to be decreased in psoriasis patients (Table II). In the analysis
of the HLA-DM alleles for the patients divided into types I and II
(Table III), the alleles associated with all psoriasis patients showed
signi¢cant di¡erences between the type I psoriasis patients and
the controls. Although no signi¢cant di¡erences were found be-
tween the type I and type II patients, probably due to the small
number of patients in each subgroup, DMAn0102 was more in-
creased and DMAn0101/0101 and DMBn0103/0103 were more de-
creased in type I compared to type II patients.We also found that
these alleles’ associations might be independent of the LD with
Cwn0602 (TableV).We performed strati¢cation analysis between
DMAn0101/0101 and DMBn0103/0103 (Table VII) in order to in-
vestigate the relationship of the two alleles with psoriasis. The
comparison of DMAn0101/0101 and DMBn0103/0103 might give
results indicating an interaction, although several of the critical
p-values were not signi¢cant, which was possibly due to the
small numbers in the 2 2 tables.We further analyzed the asso-
ciation between the haplotype of DMAn0101/0101^DMBn0103/
0103 and Cwn0602, and found that the haplotype association
might be independent of Cwn0602. These data therefore suggest
that the associated HLA-DM alleles may be an independent ge-
netic marker of psoriasis to Cwn0602, especially type I psoriasis
patients, and a factor controlled by a certain gene, located be-
tween the DMA and DMB, may provide strong protection
against psoriasis in the Korean population, independently of
Cwn0602.
In conclusion, we found associations of the TAP and the HLA-
DM alleles with psoriasis in our Korean population, suggesting
that these alleles could be genetic factors, or markers, of psoriasis.
To validate these results, however, additional studies will be re-
quired by using an increased sample size and family samples,
and investigating the location of the antigen processing genes’
region, as well as their functional roles.
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